MedTrace Logo

SDM for Stroke Prevention in Atrial Fibrillation

NCT02905032 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1186

Last updated 2022-01-25

Study results available
· View outcomes & findings →

Summary

The objective of this project is to evaluate a treatment decision aid for patients with atrial fibrillation.

Conditions

Interventions

BEHAVIORAL

Decision Aid

Observation of clinical encounter using the electronic decision aid to facilitate treatment option conversation between clinician and patient.

Sponsors & Collaborators

  • Park Nicollet Clinic

    collaborator OTHER

  • Hennepin County Medical Center, Minneapolis

    collaborator OTHER

  • National Heart, Lung, and Blood Institute (NHLBI)

    collaborator NIH

  • Mayo Clinic

    lead OTHER

Principal Investigators

  • Peter A Noseworthy · Mayo Clinic

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-09-01
Primary Completion
2019-06-27
Completion
2020-06-27

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02905032 on ClinicalTrials.gov